Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
During the past 5 years, PT Medela Potentia Tbk's highest 3-Year average EPS without NRI Growth Rate was 10.80% per year. The lowest was 2.20% per year. And the median was 6.50% per year.
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
PT Medela Potentia Tbk EPS (Diluted) Related Terms
PT Medela Potentia Tbk EPS (Diluted) Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:MDLA vs MCK, CAH, COR: EPS (Diluted) Comparison
For the Medical Distribution subindustry, PT Medela Potentia Tbk's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medela Potentia Tbk PE Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Medela Potentia Tbk's PE Ratio distribution charts can be found below:
* The bar in red indicates where PT Medela Potentia Tbk's PE Ratio falls into.
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
PT Medela Potentia Tbk's Diluted EPS for the fiscal year that ended in Dec. 2025 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp28.23
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medela Potentia Tbk (ISX:MDLA) has a EPS (Diluted) of Rp28.23 as of Mar. 2026. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on PT Medela Potentia Tbk and its competitors.
Is PT Medela Potentia Tbk's EPS (Diluted) too high?
PT Medela Potentia Tbk's current EPS (Diluted) is Rp28.23. Overall, PT Medela Potentia Tbk has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PT Medela Potentia Tbk's EPS (Diluted) compare to MCK and CAH?
PT Medela Potentia Tbk's EPS (Diluted) of Rp28.23 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Diluted) for a Medical Distribution company?
A good EPS (Diluted) depends on the Medical Distribution industry context. However, EPS (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Diluted) mean?
A high EPS (Diluted) can signal that a stock is expensive relative to its fundamentals. Earnings per share (diluted) equals net income divided by the diluted average shares outstanding. View historical data on PT Medela Potentia Tbk and its competitors. PT Medela Potentia Tbk's current EPS (Diluted) is Rp28.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medela Potentia Tbk stock overvalued right now?
PT Medela Potentia Tbk (ISX:MDLA) has a current EPS (Diluted) of Rp28.23. The current EPS (Diluted) is Rp28.23. PT Medela Potentia Tbk's overall GF Score™ is 13/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Diluted) calculated?
EPS (Diluted) is calculated from a company's financial statements. For PT Medela Potentia Tbk (ISX:MDLA), the current EPS (Diluted) is Rp28.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PT Medela Potentia Tbk is a healthcare-focused holding company engaged in pharmaceutical distribution, medical device manufacturing, and marketing services. It is engaged in the distribution and marketing of pharmaceutical products, health products, and medical devices. It also manufactures medical devices and implements web portals and digital platforms for commercial purposes through its subsidiaries. The Company manages three main operating segments, namely pharmaceutical products, healthcare products, and medical devices.
13GF Score
Get the complete analysis for ISX:MDLA
EPS (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:MDLA has been successfully added to your 
